Remove 2028 Remove Insurance Remove Vaccines
article thumbnail

Merck agrees to acquire Verona Pharma for $10bn

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Keytruda, which brought in $30bn in revenue in 2024, is approaching patent expirations set in 2028, and Merck is therefore intensifying efforts to restructure its portfolio, according to a report by Reuters. Give your business an edge with our leading industry insights.

article thumbnail

RFK Jr's Decision to Replace Entire ACIP Panel "Completely Unexpected," Former Member Says

Drug Topics

announced that all current members of the CDC's Advisory Committee for Immunization Practices (ACIP) will be retired and replaced in order to “reestablish public confidence in vaccine science.” 1 “A clean sweep is necessary to reestablish public confidence in vaccine science,” Kennedy said in the release. Kennedy Jr.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RFK Jr axes vaccine advisory committee members

Pharmaceutical Technology

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. lev radin via Shutterstock. Data Insights The gold standard of business intelligence.

article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. GlobalData separates immuno-oncology treatments into six broad classes, which include bispecific antibodies, cancer vaccines, and cell therapies. Click here to watch this webinar and access the presentation.